Therapeutic validation and targeting of signalling networks that are dysregulated in intellectual disability

Francisco Bustos1,2, Greg M Findlay3

  • 1Pediatrics and Rare Diseases Group, Sanford Research, Sioux Falls, SD, USA.

The FEBS Journal
|February 25, 2022
PubMed